Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Targeting Mucosal Endothelin-A-Receptor Expression by Fluorescence Endoscopy is Feasible to Detect and Characterize Colitis-Associated Cancer in Mice.

Mücke MM, Bettenworth D, Geyer C, Schwegmann K, Poremba C, Schäfers M, Domagk D, Höltke C, Lenz P.

Inflamm Bowel Dis. 2017 Dec 19;24(1):111-122. doi: 10.1093/ibd/izx032.

PMID:
29272493
2.

Quantitative phase microscopy for evaluation of intestinal inflammation and wound healing utilizing label-free biophysical markers.

Bettenworth D, Bokemeyer A, Poremba C, Ding NS, Ketelhut S, Lenz P, Kemper B.

Histol Histopathol. 2018 May;33(5):417-432. doi: 10.14670/HH-11-937. Epub 2017 Oct 9. Review.

PMID:
28990642
3.

The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis.

Günther C, He GW, Kremer AE, Murphy JM, Petrie EJ, Amann K, Vandenabeele P, Linkermann A, Poremba C, Schleicher U, Dewitz C, Krautwald S, Neurath MF, Becker C, Wirtz S.

J Clin Invest. 2016 Nov 1;126(11):4346-4360. doi: 10.1172/JCI87545. Epub 2016 Oct 17.

4.

The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.

Stegmaier S, Leuschner I, Poremba C, Ladenstein R, Kazanowska B, Ljungman G, Scheer M, Blank B, Bielack S, Klingebiel T, Koscielniak E.

Pediatr Blood Cancer. 2017 Jan;64(1):89-95. doi: 10.1002/pbc.26206. Epub 2016 Sep 13.

PMID:
27621063
5.

PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury.

He GW, Günther C, Kremer AE, Thonn V, Amann K, Poremba C, Neurath MF, Wirtz S, Becker C.

Gut. 2017 Apr;66(4):716-723. doi: 10.1136/gutjnl-2015-311247. Epub 2016 Aug 26.

PMID:
27566130
6.

Association between theta power in 6-month old infants at rest and maternal PTSD severity: A pilot study.

Sanjuan PM, Poremba C, Flynn LR, Savich R, Annett RD, Stephen J.

Neurosci Lett. 2016 Sep 6;630:120-126. doi: 10.1016/j.neulet.2016.07.048. Epub 2016 Jul 26.

7.

Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice.

Bettenworth D, Mücke MM, Schwegmann K, Faust A, Poremba C, Schäfers M, Domagk D, Lenz P.

Clin Exp Metastasis. 2016 Aug;33(6):551-62. doi: 10.1007/s10585-016-9797-7. Epub 2016 May 4.

PMID:
27146063
8.

Detection of Early Murine Colorectal Cancer by MMP-2/-9-Guided Fluorescence Endoscopy.

Schwegmann K, Bettenworth D, Hermann S, Faust A, Poremba C, Foell D, Schäfers M, Domagk D, Lenz P.

Inflamm Bowel Dis. 2016 Jan;22(1):82-91. doi: 10.1097/MIB.0000000000000605.

PMID:
26457379
9.

Transient elastography improves detection of liver cirrhosis compared to routine screening tests.

Göbel T, Schadewaldt-Tümmers J, Greiner L, Poremba C, Häussinger D, Erhardt A.

World J Gastroenterol. 2015 Jan 21;21(3):953-60. doi: 10.3748/wjg.v21.i3.953.

10.

Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer.

Poremba C, Uhlendorff J, Pfitzner BM, Hennig G, Bohmann K, Bojar H, Krenn V, Brase JC, Haufe F, Averdick M, Dietel M, Kronenwett R, Denkert C.

Virchows Arch. 2014 Oct;465(4):409-17. doi: 10.1007/s00428-014-1652-0. Epub 2014 Sep 14.

11.

Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.

Matuschek C, Lehnhardt M, Gerber PA, Poremba C, Hamilton J, Lammering G, Orth K, Budach W, Bojar H, Bölke E, Peiper M.

Eur J Med Res. 2014 Feb 3;19:6. doi: 10.1186/2047-783X-19-6.

12.

[Histopathological differential diagnostics in context of joint implant allergic reactions].

Krenn V, Poremba C, Schneider J, Kendoff D, Gehrke T, Kretzer JP, Thomsen M, Huber M.

Orthopade. 2013 Aug;42(8):614-21. doi: 10.1007/s00132-012-2034-4. German. Erratum in: Orthopade. 2013 Dec;42(12):1046-7.

PMID:
23867891
13.

L-arginine-NO-cGMP signalling pathway in pancreatitis.

Buchwalow I, Schnekenburger J, Tiemann K, Samoilova V, Bankfalvi A, Poremba C, Schleicher C, Neumann J, Boecker W.

Sci Rep. 2013;3:1899. doi: 10.1038/srep01899.

14.

[Revised consensus classification. Histopathological classification of diseases associated with joint endoprostheses].

Krenn V, Morawietz L, Kienapfel H, Ascherl R, Matziolis G, Hassenpflug J, Thomsen M, Thomas P, Huber M, Schuh C, Kendoff D, Baumhoer D, Krukemeyer MG, Perino G, Zustin J, Berger I, Rüther W, Poremba C, Gehrke T.

Z Rheumatol. 2013 May;72(4):383-92. doi: 10.1007/s00393-012-1099-0. German.

PMID:
23446461
15.

[Synovialitis of the arthrofibrotic type: criteria of a new synovialitis type for the diagnosis of arthrofibrosis].

Krenn V, Ruppert M, Knöß P, Kendoff D, Poremba C, Thomsen M, Skutek M, Hassenpflug J, Ascherl R, Krukemeyer MG, Matziolis G, Thomas P, Gehrke T.

Z Rheumatol. 2013 Apr;72(3):270-8. doi: 10.1007/s00393-012-1076-7. German.

PMID:
23223892
16.

Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor.

Thier S, Lorenz D, Nothnagel M, Poremba C, Papengut F, Appenzeller S, Paschen S, Hofschulte F, Hussl AC, Hering S, Poewe W, Asmus F, Gasser T, Schöls L, Christensen K, Nebel A, Schreiber S, Klebe S, Deuschl G, Kuhlenbäumer G.

Neurology. 2012 Jul 17;79(3):243-8. doi: 10.1212/WNL.0b013e31825fdeed. Epub 2012 Jul 3.

17.

[Indications for tissue biopsy. Diagnostic histopathology in rheumatological diseases].

Krenn V, Poremba C, Dierkes C.

Z Rheumatol. 2012 Jun;71(4):297-311; quiz 312-3. doi: 10.1007/s00393-012-0979-7. German.

PMID:
22699218
18.

High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients.

Grunewald TG, Ranft A, Esposito I, da Silva-Buttkus P, Aichler M, Baumhoer D, Schaefer KL, Ottaviano L, Poremba C, Jundt G, Jürgens H, Dirksen U, Richter GH, Burdach S.

Ann Oncol. 2012 Aug;23(8):2185-90. doi: 10.1093/annonc/mdr605. Epub 2012 Feb 8.

PMID:
22317770
19.

High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.

Göbel T, Erhardt A, Herwig M, Poremba C, Baldus SE, Sagir A, Heinzel-Pleines U, Häussinger D.

J Med Virol. 2011 Jun;83(6):968-73. doi: 10.1002/jmv.22048.

PMID:
21503908
20.

Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.

Gluz O, Wild P, Liedtke C, Kates R, Mendrik H, Ehm E, Artinger V, Diallo-Danebrock R, Ting E, Mohrmann S, Poremba C, Harbeck N, Nitz U, Hartmann A, Gaumann A.

Breast Cancer Res Treat. 2011 Apr;126(3):643-51. doi: 10.1007/s10549-011-1377-6. Epub 2011 Feb 12.

PMID:
21318601
21.

Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.

Armeanu-Ebinger S, Bonin M, Häbig K, Poremba C, Koscielniak E, Godzinski J, Warmann SW, Fuchs J, Seitz G.

Int J Oncol. 2011 Apr;38(4):993-1000. doi: 10.3892/ijo.2011.921. Epub 2011 Jan 24.

PMID:
21271214
22.

Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS).

Stegmaier S, Poremba C, Schaefer KL, Leuschner I, Kazanowska B, Békássy AN, Bielack SS, Klingebiel T, Koscielniak E.

Pediatr Blood Cancer. 2011 Sep;57(3):406-14. doi: 10.1002/pbc.22958. Epub 2011 Jan 19.

PMID:
21254373
23.

The psychosocial burden of essential tremor in an outpatient- and a community-based cohort.

Lorenz D, Poremba C, Papengut F, Schreiber S, Deuschl G.

Eur J Neurol. 2011 Jul;18(7):972-9. doi: 10.1111/j.1468-1331.2010.03295.x. Epub 2011 Jan 18.

PMID:
21244579
24.

[Chronic hepatitis B with an unexpected coinfection].

Göbel T, Erhardt A, Richter J, Poremba C, Häussinger D.

Med Klin (Munich). 2010 Nov;105(11):827-30. doi: 10.1007/s00063-010-1141-4. Epub 2010 Dec 7. German.

PMID:
21136241
25.

Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.

Smida J, Baumhoer D, Rosemann M, Walch A, Bielack S, Poremba C, Remberger K, Korsching E, Scheurlen W, Dierkes C, Burdach S, Jundt G, Atkinson MJ, Nathrath M.

Clin Cancer Res. 2010 Aug 15;16(16):4256-67. doi: 10.1158/1078-0432.CCR-10-0284. Epub 2010 Jul 7.

26.

Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.

Aryee DN, Niedan S, Kauer M, Schwentner R, Bennani-Baiti IM, Ban J, Muehlbacher K, Kreppel M, Walker RL, Meltzer P, Poremba C, Kofler R, Kovar H.

Cancer Res. 2010 May 15;70(10):4015-23. doi: 10.1158/0008-5472.CAN-09-4333. Epub 2010 May 4.

27.

Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.

Le Deley MC, Delattre O, Schaefer KL, Burchill SA, Koehler G, Hogendoorn PC, Lion T, Poremba C, Marandet J, Ballet S, Pierron G, Brownhill SC, Nesslböck M, Ranft A, Dirksen U, Oberlin O, Lewis IJ, Craft AW, Jürgens H, Kovar H.

J Clin Oncol. 2010 Apr 20;28(12):1982-8. doi: 10.1200/JCO.2009.23.3585. Epub 2010 Mar 22.

PMID:
20308673
28.

[Histopathological degeneration score of fibrous cartilage. Low- and high-grade meniscal degeneration].

Krenn V, Kurz B, Krukemeyer MG, Knoess P, Jakobs M, Poremba C, Möllenhoff G.

Z Rheumatol. 2010 Sep;69(7):644-52. doi: 10.1007/s00393-010-0609-1. German.

PMID:
20213088
29.

[Analysis of the statistical value of various commercially available stool tests - a comparison of one stool sample in correlation to colonoscopy].

Möslein G, Schneider C, Theilmeier A, Erckenbrecht H, Normann S, Hoffmann B, Tilmann-Schmidt D, Horstmann O, Graeven U, Poremba C; Verein Düsseldorf-gegen-Darmkrebs e. V.

Dtsch Med Wochenschr. 2010 Mar;135(12):557-62. doi: 10.1055/s-0030-1247866. Epub 2010 Mar 5. German.

PMID:
20209426
30.

[Cystic desmoplastic small round cell tumor: tumor development from cystic-"mesothelioblastic" areas?].

Kuhnen C, Schäfer KL, Franke K, Poremba C.

Pathologe. 2010 Mar;31(2):142-9. doi: 10.1007/s00292-009-1258-5. German.

PMID:
20066421
31.

Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy.

Gluz O, Mengele K, Schmitt M, Kates R, Diallo-Danebrock R, Neff F, Royer HD, Eckstein N, Mohrmann S, Ting E, Kiechle M, Poremba C, Nitz U, Harbeck N.

J Clin Oncol. 2009 Dec 20;27(36):6144-51. doi: 10.1200/JCO.2008.19.6261. Epub 2009 Nov 9.

PMID:
19901122
32.

Reexcision of soft tissue sarcoma: sufficient local control but increased rate of metastasis.

Rehders A, Stoecklein NH, Poremba C, Alexander A, Knoefel WT, Peiper M.

World J Surg. 2009 Dec;33(12):2599-605. doi: 10.1007/s00268-009-0262-5. Erratum in: World J Surg. 2010 Aug;34(8):1991.

PMID:
19838751
33.

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.

Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, Gabbert HE, Poremba C.

Genes Chromosomes Cancer. 2010 Jan;49(1):40-51. doi: 10.1002/gcc.20717.

PMID:
19787792
34.

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods.

Bohmann K, Hennig G, Rogel U, Poremba C, Mueller BM, Fritz P, Stoerkel S, Schaefer KL.

Clin Chem. 2009 Sep;55(9):1719-27. doi: 10.1373/clinchem.2008.122572. Epub 2009 Jul 17.

35.

Leiomyosarcoma of the inferior vena cava: radical surgery and vascular reconstruction.

Alexander A, Rehders A, Raffel A, Poremba C, Knoefel WT, Eisenberger CF.

World J Surg Oncol. 2009 Jun 26;7:56. doi: 10.1186/1477-7819-7-56.

36.

Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.

Herrero-Martín D, Osuna D, Ordóñez JL, Sevillano V, Martins AS, Mackintosh C, Campos M, Madoz-Gúrpide J, Otero-Motta AP, Caballero G, Amaral AT, Wai DH, Braun Y, Eisenacher M, Schaefer KL, Poremba C, de Alava E.

Br J Cancer. 2009 Jul 7;101(1):80-90. doi: 10.1038/sj.bjc.6605104. Epub 2009 Jun 2.

37.

Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.

Calaminus G, Schneider DT, Weissbach L, Schönberger S, Okpanyi V, Leuschner I, Poremba C, Göbel U.

Klin Padiatr. 2009 May-Jun;221(3):136-40. doi: 10.1055/s-0029-1220738. Epub 2009 May 12.

PMID:
19437360
38.

Superficial soft tissue sarcomas of the extremities and trunk.

Lachenmayer A, Yang Q, Eisenberger CF, Boelke E, Poremba C, Heinecke A, Ohmann C, Knoefel WT, Peiper M.

World J Surg. 2009 Aug;33(8):1641-9. doi: 10.1007/s00268-009-0051-1.

PMID:
19430830
39.

Long-term survival after surgery for primary hepatic sarcoma in adults.

Matthaei H, Krieg A, Schmelzle M, Boelke E, Poremba C, Rogiers X, Knoefel WT, Peiper M.

Arch Surg. 2009 Apr;144(4):339-44; discussion 344. doi: 10.1001/archsurg.2009.30.

PMID:
19380647
40.

Primary peripheral primitive neuroectodermal tumor/Ewing's tumor of the testis in a 46-year-old man-differential diagnosis and review of the literature.

Heikaus S, Schaefer KL, Eucker J, Hogrebe E, Danebrock R, Wai DH, Krenn V, Gabbert HE, Poremba C.

Hum Pathol. 2009 Jun;40(6):893-7. doi: 10.1016/j.humpath.2008.11.009. Epub 2009 Mar 9. Review.

PMID:
19269015
41.

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.

Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H; European Intergroup Cooperative Ewing's Sarcoma Study-92.

J Clin Oncol. 2008 Sep 20;26(27):4385-93. doi: 10.1200/JCO.2008.16.5720.

PMID:
18802150
42.

EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.

Ban J, Bennani-Baiti IM, Kauer M, Schaefer KL, Poremba C, Jug G, Schwentner R, Smrzka O, Muehlbacher K, Aryee DN, Kovar H.

Cancer Res. 2008 Sep 1;68(17):7100-9. doi: 10.1158/0008-5472.CAN-07-6145.

43.

A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.

Martins AS, Ordoñez JL, García-Sánchez A, Herrero D, Sevillano V, Osuna D, Mackintosh C, Caballero G, Otero AP, Poremba C, Madoz-Gúrpide J, de Alava E.

Cancer Res. 2008 Aug 1;68(15):6260-70. doi: 10.1158/0008-5472.CAN-07-3074.

44.

Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.

Gluz O, Wild P, Meiler R, Diallo-Danebrock R, Ting E, Mohrmann S, Schuett G, Dahl E, Fuchs T, Herr A, Gaumann A, Frick M, Poremba C, Nitz UA, Hartmann A.

Int J Cancer. 2008 Sep 15;123(6):1433-8. doi: 10.1002/ijc.23628.

45.

Gene Therapy of βc-Deficient Pulmonary Alveolar Proteinosis (βc-PAP): Studies in a Murine in vivo Model.

Kleff V, Sorg UR, Bury C, Suzuki T, Rattmann I, Jerabek-Willemsen M, Poremba C, Flasshove M, Opalka B, Trapnell B, Dirksen U, Moritz T.

Mol Ther. 2008 Apr;16(4):757-764. doi: 10.1038/mt.2008.7. Epub 2016 Dec 8.

PMID:
28178466
46.

Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model.

Kleff V, Sorg UR, Bury C, Suzuki T, Rattmann I, Jerabek-Willemsen M, Poremba C, Flasshove M, Opalka B, Trapnell B, Dirksen U, Moritz T.

Mol Ther. 2008 Apr;16(4):757-64. doi: 10.1038/mt.2008.7. Epub 2008 Mar 4.

47.

[Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Gabbert HE, Nitz U, Poremba C.

Verh Dtsch Ges Pathol. 2007;91:187-96. German.

PMID:
18314614
48.

Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.

Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C.

Eur J Cancer. 2008 Mar;44(5):699-709. doi: 10.1016/j.ejca.2008.01.020. Epub 2008 Feb 21.

PMID:
18294840
49.

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.

Gluz O, Nitz UA, Harbeck N, Ting E, Kates R, Herr A, Lindemann W, Jackisch C, Berdel WE, Kirchner H, Metzner B, Werner F, Schütt G, Frick M, Poremba C, Diallo-Danebrock R, Mohrmann S; West German Study Group.

Ann Oncol. 2008 May;19(5):861-70. doi: 10.1093/annonc/mdm551. Epub 2008 Jan 3.

PMID:
18174609
50.

Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography.

Stelljes M, Hermann S, Albring J, Köhler G, Löffler M, Franzius C, Poremba C, Schlösser V, Volkmann S, Opitz C, Bremer C, Kucharzik T, Silling G, Schober O, Berdel WE, Schäfers M, Kienast J.

Blood. 2008 Mar 1;111(5):2909-18. Epub 2007 Dec 5.

Supplemental Content

Loading ...
Support Center